Cargando…

Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation

BACKGROUND: Interleukin (IL)-34 and IL-38 are associated with cardiovascular disease (CVD). However, their involvement in atrial fibrillation (AF) and AF-associated adverse events remains uncertain. Therefore, we aimed to investigate their association with various AF prognostic factors in a cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jiaxue, Wu, Na, Yuan, Zhiquan, Chen, Yanxiu, Li, Chengying, Xie, Weijia, Zhang, Zhihui, Li, Yafei, Zhong, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868840/ https://www.ncbi.nlm.nih.gov/pubmed/36698935 http://dx.doi.org/10.3389/fcvm.2022.1072164

Ejemplares similares

Prediction Model of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome
por: Wu, Na, et al.
Publicado: (2023)

Role of circulating long non-coding RNA for the improvement of the predictive ability of the CHA(2)DS(2)–VASc score in patients with atrial fibrillation
por: Zhang, Yuanbo, et al.
Publicado: (2022)

Editorial: Mechanism and prevention of atrial fibrillation
por: Li, Guowei, et al.
Publicado: (2022)

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
por: Apenteng, Patricia N, et al.
Publicado: (2018)

Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry
por: Fox, Keith A A, et al.
Publicado: (2022)

Neopterin and interleukin-6 as predictors of recurrent atrial fibrillation
por: Lewicka, Ewa, et al.
Publicado: (2016)

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry
por: Camm, A John, et al.
Publicado: (2017)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Obayashi, Yuki, et al.
Publicado: (2021)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

An Automated Clinical Alert System for Newly-Diagnosed Atrial Fibrillation
por: Cook, David A., et al.
Publicado: (2015)

Stroke Severity and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation
por: Watanabe, Kotaro, et al.
Publicado: (2021)

Diagnostic Value of Delayed Contrast-Enhanced Cardiac Computed Tomography for Detecting Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
por: Li, Xiang-Nan, et al.
Publicado: (2022)

Opposing Effects of Interleukin-36γ and Interleukin-38 on Trained Immunity
por: Teufel, Lisa U., et al.
Publicado: (2023)

The value of left atrial longitudinal strain in evaluating left atrial appendage spontaneous echo contrast in non-valvular atrial fibrillation
por: Ma, Chang sheng, et al.
Publicado: (2023)

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation
por: Li, Dan, et al.
Publicado: (2022)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Role of the interleukin-17 pathway in the pathogenesis of atrial fibrillation associated with inflammation
por: Yue, Honghua, et al.
Publicado: (2021)

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer
por: Wang, Chun-Li, et al.
Publicado: (2021)

Value of baseline characteristics in the risk prediction of atrial fibrillation
por: He, Jiacheng, et al.
Publicado: (2023)

Atrial Fibrillation and Cancer
por: Hajjar, Ludhmila Abrahao, et al.
Publicado: (2021)

Prognostic value of interleukin-33, sST2, myeloperoxidase, and matrix metalloproteinase-9 in acute aortic dissection
por: Jia, Yu, et al.
Publicado: (2023)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
por: Guo, Xueyuan, et al.
Publicado: (2022)

Left atrial appendage exclusion in atrial fibrillation
por: Rozen, Guy, et al.
Publicado: (2022)

Right atrial appendage firing in atrial fibrillation
por: Baptiste, Florian, et al.
Publicado: (2022)

Research Progress of Myocardial Fibrosis and Atrial Fibrillation
por: Li, Guangling, et al.
Publicado: (2022)

Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy
por: Murakata, Yoshiko, et al.
Publicado: (2023)

Congenital Left Atrial Bands with Atrial Fibrillation
por: Jang, Won Young, et al.
Publicado: (2017)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Stroke risk evaluation for patients with atrial fibrillation: Insights from left atrial appendage
por: Fang, Runxin, et al.
Publicado: (2022)

Case report: Mechanical-electric feedback and atrial fibrillation–Revelation from the treatment of a rare atrial fibrillation caused by annular constrictive pericarditis
por: Yi, Dong, et al.
Publicado: (2023)

Predicting Late Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Atrial Fibrillation: Comparison of C2HEST and HATCH Scores
por: Han, Jingjing, et al.
Publicado: (2022)

Predictive Value of Left Atrial and Ventricular Strain for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke
por: Bufano, Gabriella, et al.
Publicado: (2022)

Editorial: Atrial fibrillation in dementia
por: Gotzmann, Michael, et al.
Publicado: (2023)

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
por: Huber, K, et al.
Publicado: (2013)

Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation
por: Diener, H.‐C., et al.
Publicado: (2015)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Re-recognize early recurrence of persistent atrial fibrillation
por: Fu, Kaixuan, et al.
Publicado: (2023)

Postoperative atrial fibrillation in patients with left atrial myxoma
por: Sahin, Muslum, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_glau88c7cgf08hk3ujl8vugg4u